Chemours Announces Voluntary Actions to Respond to North Carolina Community

June 20, 2017

Additional Measures Will Eliminate Byproduct GenX Wastewater Emissions From Fayetteville Site in North Carolina

Wilmington, Del., June 20, 2017 – The Chemours Company (Chemours) (NYSE: CC) today announced that it will capture, remove, and safely dispose of wastewater that contains the byproduct GenX generated from fluoromonomers production at its manufacturing plant in Fayetteville, North Carolina. Trace GenX amounts in the Cape Fear River to date have been well below the health screening level announced by the North Carolina Department of Health and Human Services on June 12, 2017, and the company continues to believe that emissions from its Fayetteville facility have not impacted the safety of drinking water.  However, Chemours will take these additional steps, embracing its role as a significant employer and member of the community. The capture and removal of this wastewater will commence on June 21, 2017. This action complements the abatement technology already put in place at the Fayetteville site in 2013.

Chemours will continue to work closely with local and state officials to answer questions, provide information as needed, and determine next steps.  As a new company, Chemours is built on a culture of safety and sustainability and will continue its efforts to reduce its environmental footprint.    

About The Chemours Company

The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry.  Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations.  Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and general industrial manufacturing.  Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™, Viton™, Opteon™, Freon™ and Nafion™.  Chemours has approximately 7,000 employees and 26 manufacturing sites serving approximately 4,000 customers in North America, Latin America, Asia-Pacific and Europe.  Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.  For more information please visit chemours.com

Forward-Looking Statements

This press release contains forward-looking statements, within the meaning of the federal securities laws, that involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. The words "believe," "expect," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date the statements were made. These forward-looking statements address, among other things, the offering, our agreement with DuPont relating to the MDL Settlement, resolution of environmental liabilities, litigation and other contingencies, anticipated future operating and financial performance, business plans and prospects, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond Chemours' control. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include whether the offering is completed and other risks, uncertainties and other factors discussed in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2016. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

CONTACT
MEDIA
Alvenia Scarborough
Director of Brand Marketing and Corporate Communications
+1.302.773.4507
media@chemours.com

INVESTORS
Alisha Bellezza
Treasurer and Director of Investor Relations
+1.302.773.2263
investor@chemours.com

Investor Contacts

Alisha Bellezza
Treasurer and Director of Investor Relations
+1.302.773.2263

Kaitlin Hein
Investor Relations Manager
+1.302.773.2263

Lori Ursomarso
Investor Relations Specialist
+1.302.773.1062

investor@chemours.com

Media Inquiries

Alvenia Scarborough
Director, Brand and Corporate Communications
+1.302.773.4506

Stay up-to-date

Receive the latest news and information via e-mail.

Mailing Lists *




Email Address *


News Media Center

View company news releases, media tools, images, videos, contacts, and more.

Ethics Hotline

FAQs

Learn more about how Chemours began, what our new company means for customers, and how being part of Chemours will affect individual business units and brands.

Join Our Team

Join a startup that is already thousands strong. Chemours careers extend from chemical engineering to marketing, information technology to operations management.

Areas of Opportunity